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ABSTRACT 
 
RNase P, an essential enzyme, is an exceptionally interesting system for the study 
of protein-protein and protein-RNA interactions in catalysis. Composed of both RNA and 
protein subunits, the complex catalyzes the hydrolytic cleavage of the 5’ leader sequence 
of precursor tRNA, a vital step in tRNA processing. While bacterial RNase P is a true 
ribozyme with a catalytic RNA subunit, it requires a single associated protein for function 
in vivo. 
RNase P from archaeal and eukaryal organisms are also composed of requisite 
protein and RNA subunits.  Coordinating at least nine proteins, eukaryotic RNase P is 
much more complex than the single-protein bacterial system, although both utilize a 
single RNA subunit.  The archaeal enzyme is of intermediate complexity with at least 
four protein subunits. The functional roles of the RNA and protein subunits are 
reasonably well characterized in the bacterial system, but how these roles differ in 
organisms that use more protein subunits remains a mystery. Archaeal RNase P, then, is 
clearly a prime target for furthering our understanding of this enzyme in particular and of 
macromolecular cooperation for catalysis in general.   
Pfu Rpp30 is the largest protein subunit of RNase P in the archaebacterium 
Pyrococcus furiosus (Pfu).  Here, we show that Rpp30 has been recombinantly expressed 
and isolated by two different purification methods. NMR spectra of the isolated protein 
revealed dispersed signals characteristic of a well-folded protein, and optimization of 
spectral quality and subsequent three-dimensional experiments allowed ~90% of 206 
assignable backbone amide resonances. These data were subsequently used to 
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characterize an interaction with Pop5, a protein binding partner of Rpp30.  Widespread 
chemical shift perturbations observed for each protein’s NMR spectrum suggest the 
formation of a tight complex, and mapping perturbations onto three-dimensional 
structures of Pop5 and Rpp30 indicated a previously unknown (and since corroborated) 
binding interface between the two molecules. 
A detailed model of the Rpp30-Pop5 interface will be useful in designing future 
experiments to fully understand the functional contribution of RNase P subunit 
interactions.  In addition, having high quality and assigned NMR spectra of Rpp30 opens 
the door for a detailed investigation of its involvement with other subunits using various 
NMR techniques.   
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CHAPTER 1 
INTRODUCTION 
1.1 RNase P: 
 RNase P is perhaps best known from the 1989 Nobel Prize in Chemistry1.  That 
year, Sidney Altman was awarded for discovering that RNase P, a ribonucleoprotein 
complex, is a true RNA catalyst2,3.  Namely, he showed that the RNA subunit of bacterial 
RNase P is catalytic on its own, demonstrating that the RNA (and not the protein) is the 
enzyme’s catalytic component.  Now, over twenty years after this initial discovery, the 
actual machinery of RNase P catalysis is still under investigation.  
 Despite the complexity of its mechanism, RNase P performs a straightforward 
biological function; the enzyme catalyzes the hydrolytic cleavage of precursor tRNA4.  In 
order for freshly transcribed tRNA to become mature and functional, several post-
transcriptional modifications must take place.  RNase P performs one of these necessary 
modifications by removing a 5’ leader sequence from precursor tRNA4,5(Fig 1.1).  
Considering the variety among the 64 recognized tRNA sequences5, RNase P achieves 
surprising accuracy in cleavage site selection.  In vivo, this straightforward cleavage step 
is essential for proper tRNA functioning, and is thereby also vital for any living cell. 
 Accordingly, RNase P can be postulated to be necessary in all organisms, and it 
has been found in all domains of life6.  Although several aspects have been conserved 
over evolutionary time, the enzyme has a particularly interesting developmental history. 
 In bacteria, RNase P consists of one large RNA subunit (~120kDa, referred to as 
‘PRNA’) and a small protein cofactor (~15kDa).  Altman’s initial experiments and 
corroborating studies2,7,8 indicate that bacterial PRNA is catalytically active in vitro 
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without protein.  The protein is quite important, however, because it improves the 
enzyme’s turnover rate 9,10,11, lowers the in vitro magnesium requirement 12, and is 
required for in vivo activity 13.  Presently, the protein subunit is hypothesized to be 
involved in some or all of the following: stabilizing the PRNA structure, recognizing the 
tRNA substrate, and promoting dimerization of the holoenzyme14.   
 The RNase P complex in eukaryotes is surprisingly quite different from the 
bacterial enzyme despite its conserved function15.  There remains a single large RNA 
subunit that shares sequence homology with bacterial PRNA.  However, secondary 
structure mapping based on conserved sequence elements indicates that several structural 
components of bacterial PRNA are absent in its eukaryotic counterpart16,17(Fig 1.2), 
which may be the reason eukaryotic PRNA has not been demonstrated to be active in 
vitro.  In addition to a truncated PRNA, the eukaryotic enzyme has at least nine 
associated protein cofactors (ranging in size from ~15-100 kDa)18, none of which shares 
sequence homology with the bacterial protein15.  Overall, the eukaryotic enzyme is not as 
well characterized as the bacterial enzyme due to this daunting complexity. 
1.2 Archaeal RNase P: 
Archaea, have an RNase P holoenzyme representing a hybrid of the eukaryotic 
and bacterial enzymes (Fig 1.2).  There are two classes of PRNA in this domain.  The 
“ancestral” Class A enzyme from most species of archaebacteria (including Pyrococcus 
furiosus (Pfu) and Pyrococcus horikoshii (Pho)) closely resembles the consensus 
bacterial PRNA, lacking only a few secondary structure elements19.  Class A PRNA’s 
from several archaeal organisms have been shown to be partially active in the absence of 
proteins in vitro, although only in solutions containing both monovalent and divalent ions 
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and having extreme (~4M) ionic strengths20.  The second class of archaeal PRNA’s, 
Class M, groups more truncated versions of the molecule that bear a closer resemblance 
to eukaryotic PRNA19.  Accordingly, Class M PRNA requires protein subunits to perform 
catalysis in vitro20.  Both classes can be reconstituted when some or all of four protein 
cofactors are included21,22,(Gopalan unpublished data).  A fifth protein has been identified in Pho 
that increases the optimum temperature of the reconstituted enzyme23, but the protein is 
also involved with other ribonucleoprotein complexes and has not been implicated with 
other model organisms.  In contrast, the other four proteins are homologous to four of the 
eukaryotic RNase P proteins, but they have no apparent sequence homology to the 
bacterial protein subunit24.  In addition, the specific function of any of the four main 
proteins is presently unknown. 
 Thus, RNase P holds a number of evolutionary mysteries that invite further study.  
It is hypothesized that archaeal and bacterial domains have branched from a common 
ancestor that perhaps utilized a protein-free RNase P, accounting for the similarity in 
RNA subunits between the two domains despite the lack of homology in the protein 
components.  The catalytic activity of homologous PRNA’s isolated from these two 
domains of life compounded with their dissimilar protein complements lends credence to 
an “RNA World” model in which RNA catalytic machinery has been largely usurped by 
protein components over evolutionary time25.  Eukaryotic RNase P represents further 
evolution on the archaeal branch, being composed of a number of homologous subunits 
and continuing the apparent progression from RNA to protein catalytic machinery.  In 
RNase P, we have biomolecular “snapshots” of different stages in this progression, 
offering an exceptional model for studying ribozyme evolution. 
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 Living near 100 oC thermal vents, Pyrococcus furiosus (Pfu) is a 
hyperthermophilic archaebacterium.  Aside from having particularly thermostable 
biomolecules, Pfu RNase P is one of the best characterized RNase P holoenzymes from 
Archaea.  The enzyme has been reconstituted in vitro as PRNA + four proteins (Pfu 1816, 
Pfu 1613, Pfu 1378 and Pfu 1914, which will be referred to by the names of their human 
homologues: Rpp29, Rpp21, Pop5 and Rpp30 respectively); partial subsets of the 
subunits have also shown catalytic activity (PRNA + Rpp21 + Rpp29 and PRNA + Pop5 
+ Rpp30)(Gopalan, unpublished data), which supports protein-protein interactions identified from 
yeast two-hybrid data observed for the closely related organisms Pyrococcus horikoshii 
(Pho)26 and Methanobacter thermoautotrophicus (Mth)27.  Gel retardation assays for Pho 
suggest some degree of association with PRNA for each of the four proteins22.  Both 
protein-protein and protein-RNA interactions are further corroborated by yeast two and 
three-hybrid assays from homologues in the human system28 (Fig 1.3). 
Structural data from Pfu Rpp21(Foster, unpublished data), Pfu Pop529, and Mth 
Rpp2921,are available and match structures of their homologues in Archaeoglobus 
fulgidus (Afu) and Pho 30,31,32,33,34.  Furthermore, a crystal structure of Pho Rpp30 has 
been solved35.  The archaeal proteins all adopt canonical folds:  Rpp29 has a beta-barrel 
fold, Rpp21 contains a zinc ribbon, Pop5 adopts the RRM (RNA recognition motif) fold, 
and Rpp30 is a TIM-barrel protein. 
1.3 Understanding Subunit Interactions: 
 Ribonucleoprotein (RNP) complexes in general are extremely important in the 
cell, most evidently in the ribosome, but many details about the principles of protein-
RNA interactions remain a mystery.  A better understanding of RNase P’s subunit 
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interactions will elucidate how protein components complement RNA roles in the 
enzyme36.  Protein-RNA interactions are also involved in RNase P’s amazing selectivity 
for tRNA-like substrates over other RNA’s composed of the same four nucleotide 
types37. The enzyme’s selectivity has inspired engineering efforts for targeted gene 
therapy and antiviral technologies based on the bacterial PRNA38, and further information 
about protein roles in catalysis for any RNase P would surely be beneficial in this 
objective as well. 
 The intricate structures of RNase P and its substrate are fundamental to the overall 
reaction.  In eukaryotes, RNase P has several RNA substrates besides tRNA, but all of 
them have a tRNA-like structural profile near the cleavage site39.  In fact, deletion 
mutations in tRNA have been used to demonstrate that such structural elements (acceptor 
stem, T-stem, and T-stem loop) are necessary40 and sufficient41 for efficient RNA 
processing by bacterial RNase P.  Much phylogenetic, footprinting, and crosslinking 
work has gone into modeling the bacterial RNase P complex and has succeeded in 
identifying a conserved PRNA active site and rough binding interfaces of the 
components42,43,49.  Combined with structural data for the isolated components from 
several organisms44,45,46,47,48, this research has culminated in a three-dimensional model 
of the holoenzyme49(Fig 1.4). 
 Subunit interactions of RNase P from Archaea and Eukaryota are not so well-
characterized.  The eukaryotic enzyme has been partially reconstituted from cell extract50, 
but a complete reconstitution using recombinantly expressed proteins has yet to be 
achieved.  A putative interaction network has been derived for the eukaryal holoenzyme 
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from yeast two- and three-hybrid screens28, and the only structural information about the 
complex comes from database mining51 or homology modeling after archaeal proteins.    
Study of archaeal RNase P is further along; the enzyme has been reconstituted 
with four or fewer proteins, tentative subunit interactions have been identified by yeast 
two- and three-hybrid screens, and the structures of all four proteins have been 
determined (as described in section 1.2).  Still, a robust three-dimensional model of the 
archaeal holoenzyme is lacking and with it, a detailed model of the mechanism of the 
enzyme. 
1.4 NMR Spectroscopy of Proteins
52,53
: 
 X-ray crystallography is by no means the only technique for characterizing 
macromolecular structures, and NMR spectroscopy of biological macromolecules is a 
robust and growing field as well.  Although these techniques have almost nothing in 
common in terms of data collection, both can be used to obtain 3D structural models of 
macromolecules.  Collection of NMR data, although generally more time-consuming than 
X-ray data, also provides information about the dynamics of the observed molecule in 
solution, which is potentially much more insightful than static properties observed in the 
artificially rigid confines of a crystal. 
 One of the most ubiquitous means of observing proteins with NMR is via the 15N 
HSQC (Heteronuclear Single Quantum Correlation) spectrum.  The HSQC pulse 
sequence first excites 1H nuclei, then administers a series of pulses that transfers the 
excitation from the hydrogen to an adjacent 15N nucleus.  Varying the delay between a 
pair of 15N pulses in this sequence allows the 1H signals to be modulated according to the 
chemical shift of the attached 15N, giving rise to the second dimension of the spectrum.  
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The reason this experiment is so fundamental to biomolecular NMR study is that it 
detects only protons covalently bonded to 15N atoms.  Although 15N is found in very low 
natural abundance, a biomolecular sample can be isotopically enriched with 15N or other 
NMR-active nuclei by growing recombinant cells in isotopically enriched media.  For 
15N-enriched proteins, an HSQC spectrum gives information about every amide proton on 
the backbone as well as side-chain amide protons. 
 Using a variety of three-dimensional spectra with uniformly labeled 15N- and 13C-
labeled protein, each of the amide resonances that appear on the HSQC spectrum can be 
assigned to its corresponding position in the protein’s primary sequence (discussed in 
chapter 4).  Obtaining “assignments” for the HSQC spectrum is the critical first step for 
translating NMR data into biomolecularly relevant information. In addition to being a 
major step toward structural characterization of a protein, an assigned HSQC allows the 
spectroscopist to take advantage of a number of techniques that describe the status of 
molecules in solution.  For example, well-structured versus unstructured regions can be 
gauged based on signal intensity, and secondary structural features can be predicted 
based on database comparisons of the observed chemical shifts. 
Particularly relevant for our purposes with RNase P, protein or nucleic acid atoms 
will experience a change in chemical environment upon interacting with other molecules 
(either from direct interaction or conformational changes), which translates into spectral 
changes.  Thus, a binding event can be directly observed when a ligand or binding partner 
is added.  If the changes are recorded for an assigned HSQC, the perturbations can be 
used to identify what residues are involved in the binding event, which, when combined 
with structural data, can be used to describe the location of binding sites.  For example, 
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such experiments were conducted for Pfu Rpp2921, which identified a strong 
Rpp29/PRNA interaction and located a putative binding site on the protein (Fig 1.5). 
 NMR characterization of each of the RNase P components will be useful for 
piecing together a three-dimensional model of the holoenzyme.  Not only does the 
approach afford detailed information about biomolecular interactions, but it affords a 
powerful source of data by which future hypotheses (about, say, assembly pathways or 
involvement of particular residues) can be readily tested. 
 The power of NMR is not unlimited, however, and there are several substantial 
caveats to be considered.  Perhaps most relevant to the present study is the limited range 
of molecular sizes from which well-resolved data can be obtained.  First, a larger 
molecule will be composed of more atoms, which will give rise to more spectral peaks; as 
spectral resolution is limited, large numbers of peaks will eventually begin to overlap, 
becoming indistinguishable.  This problem is confounded by the fact that larger 
molecules tumble more slowly in solution, which results in faster relaxation of spins and 
a decrease in NMR signal.  Since the relaxation time is inversely proportional to the 
correlation time of a molecule (τc), the size limitation of NMR is roughly illustrated by 
the Stoke’s equation, which gives τc for a sphere: 
 
(ηw is the viscosity of the solvent, rH is the hydrated radius, kB is Boltzmann’s constant 
and T is the temperature54).  As the size and effective radius of the molecule increases, so 
does the correlation time, which means it will take longer for the molecule to reorient, 
leading to a decay of the NMR signal (which is dependent upon randomized orientation). 
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 NMR characterization of proteins and complexes has typically been limited to 
molecules of less than ~30 kDa.  However, technical improvements are constantly 
advancing the field.  Larger magnets, cryogenic probes, and TROSY (transverse 
relaxation-optimized spectroscopy) pulse sequences that are specialized for large 
molecules are making NMR characterization of larger molecules more tractable55,56.  
Study of hyperthermophile-derived archaeal RNase P can take advantage of high-
temperature experiments (heat decreases τc, which is apparent from the Stoke’s equation 
above), and so with selective labeling or fragmentation of the complex, NMR 
characterization is a challenging but feasible endeavor.    
1.5 Specific Aims: 
 The long-term goal of the present study is to clarify the nature of archaeal RNase 
P subunit interactions using information about molecular structure and dynamics that is 
accessible by NMR spectroscopy.  The structure-function relationships among interacting 
subunits will enable the construction of a 3D functional model and provide a launchpad 
for targeted manipulations and a precise understanding of the enzyme. 
 This dissertation reports progress made toward understanding archaeal RNase P 
through work on the Pfu Rpp30 subunit.  Namely, completion of or significant progress 
on each of the following aims will be discussed in the following chapters. 
Aim 1:  Recombinantly express and purify the protein.  The initial objective was to 
analyze whether well-folded Rpp30 could be harvested from E. coli in large enough 
quantities and purified to a suitable degree for further detailed characterization. 
Aim 2:  Establish and optimize a high-yield purification.  As NMR was to be the primary 
tool for structure-function characterization of multiple interactions, a preparation protocol 
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yielding protein in very high quantity and purity was essential to counterbalance the costs 
of isotopic media and the reagent demands of NMR. 
Aim 3:  Characterize interactions between Rpp30 and other RNase P subunits.  NMR 
spectroscopy of Rpp30 in isolation and in complex with other subunits can be used to 
describe changes that take place in portions of the molecule that engage with binding 
partners; this can be accomplished without completely solving the Pfu Rpp30 structure 
using a crystal structure of the closely related (68% identity, 82% similarity) Pho Rpp30 
as a model (Fig 1.6). 
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Figure 1.1: RNase P catalyzes tRNA maturation through cleavage of the 5' leader 
sequence.  The enzyme recognizes the acceptor stem, T-stem, and T-loop elements of the 
substrate.
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Figure 1.2:  RNA subunits of RNase P from different organisms illustrate similarities 
and differences in predicted secondary structure.  Major paired regions (P1-P19) are 
labeled on bacterial and eukaryotic RNA's.  Archaeal RNA's are marked at the 
universally conserved P4 pairing region (adapted from16). 
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Figure 1.3:  Interactions between archaeal RNase P proteins and PRNA subunits are 
starting to come to light.  Three-dimensional structures of each of the four proteins are 
available.  Those shown are from Pho except Pop5, which is from Pfu.  Arrows indicate 
interactions identified from yeast two- and three-hybrid assays in human    RNase P28.  
Other methods have indicated robust protein interactions in the archaeal system, 
identifying Rpp30-Pop5 and Rpp29-Rpp21 complexes (indicated by bold arrows). 26, 27, 33, 
34 
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Figure 1.4:  A recently proposed model of the bacterial holoenzyme illustrates the size 
ratios of the PRNA (gray), tRNA (green), and protein (red) subunits based on 
crystallographic structures of the isolated molecules48.  The red arrow points to the 
protein binding site as identified by crosslinking and footprinting experiments.  Similar 
studies have guided the positioning of the RNA in the model. 
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Figure 1.5: An example of using HSQC chemical shift perturbations (left) between free 
(black) and bound (red) states mapped onto an NMR structure of Pfu Rpp29 (right).  The 
magnitude of the peak movement has been mapped as a gradient from gray to red (green 
residues could not be determined)21. 
 16 
 
 
Figure 1.6:  Sequence alignment between Pfu Rpp30 and Pho Rpp30 in the top panel 
shows close homology between the proteins.  The bottom panel aligns Rpp30 
homologues from four archaebacteria (Pfu, Pho, Mth, and Mja) and two eukaryotes 
(Homo Sapiens(Hsa) and Saccaromyces Cerevisceae (Sce)).  Red-shaded residues are 
conserved and blue-framed residues have a global similarity score >0.7.  Alignment was 
performed using CLUSTALW67 and colored according to similarity by using a Risler 
scoring matrix68 using the program ESPript69. 
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CHAPTER 2 
INITIAL CHARACTERIZATION OF Pfu Rpp30 
2.1 Introduction: 
 Pyrococcus furiosus (Pfu) is one of the three archaebacteria from which RNase P 
activity has been reconstituted in vitro.  Enzymatic activity has been observed in RNase P 
isolated from cultured Pfu cells; recombinantly expressed proteins combined with RNA 
transcribed in vitro have also been successfully reconstituted into functional RNase P21.  
Like other archaebacteria, this hyperthermophile has at least four RNase P proteins 
(Rpp29, Rpp21, Pop5, and Rpp30).  In our laboratory, structures have been solved for 
Mth Rpp2921 and Pfu Pop529, and structural characterization of Pfu Rpp29 is well 
underway, leaving only the Rpp30 subunit unsolved.  Although there is substantial 
evidence for important interactions amongst the archaeal RNase P subunits, our 
understanding of their individual roles in the holoenzyme is incomplete. 
 The present project set out to address the functional and structural role(s) of the 
Rpp30 subunit.  Although not absolutely essential for in vitro cleavage activity by the 
RNA subunit, only ~1% enzymatic activity has been observed in the absence of this 
critical component22.  Detailed structural information will be important in refining our 
understanding Rpp30’s role, but the first step in the characterization of a protein is its 
isolation, and NMR study demands particularly large amounts (~0.5 µmol) of protein.  
This objective seemed quite tractable due to some advantageous properties of Rpp30:  1) 
the protein is derived from a hyperthermophile and should therefore be stable in room-
temperature purification and high-temprerature NMR experiments; 2) the protein has a 
very high isoelectric point (9.7) thereby facilitating purification; and 3) the protein has no 
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cysteine residues, eliminating the possibility of nonspecific inter- or intra-molecular 
disulfide formation.  Although these factors did not result in facile purification, the initial 
steps of the project succeeded in overexpressing Pfu Rpp30 in E. coli and subsequently 
purifying it in its native form.    
2.2 Materials and Methods: 
2.2.1 Protein Expression 
 The Pfu Rpp30 gene (PF1914 from Pyrococcus furiosus DSM 3638) was first 
amplified from Pfu genomic DNA provided by Dr. Adams’ laboratory (U. of Georgia) by 
using PCR with gene-specific primers.  The gene was subsequently cloned into the 
bacterial expression vector pET33b by Walter Woznick (Dr. Gopalan’s laboratory, OSU) 
with a standard restriction digestion and ligation protocol (NEB).  E. coli BL21(DE3) 
cells were transformed with the plasmid by electroporation and grown at 37°C in 1L 
flasks of LB medium supplemented with 34 µg/liter chloramphenicol and 50 µg/liter 
kanamycin. The cells were induced by addition of 1 mM IPTG when the cells reached 
OD600 ≈ 0.6 (mid-log phase).  After 4 hours of induction, cells were harvested by 
centrifugation (15 min, 5,000 × g, 4 °C), and stored at -20 °C. Thawed cells from 1 liter 
were suspended in 30 mL of lysis buffer (25 mM Tris, pH 7.3, 25 mM KCl) and 
sonication over ice was used to lyse the cells.  Finally, soluble and insoluble components 
of the lysate were separated by centrifugation (15 min, 26,000 × g, 25 °C). 
2.2.2 Protein Purification: Soluble Fraction 
 The soluble lysate was transferred to a fresh container where solid KCl and a 
dilute HCl solution were added to change the solution conditions to 25 mM Tris, pH 5.0, 
1 M KCl.  The solution was incubated at 25 oC for ~48 h. until precipitation of 
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contaminant proteins was complete.  After separating the soluble and insoluble portions, 
the soluble fraction was added to an equal volume of water to dilute the KCl to 500mM.  
To precipitate nucleic acids, 10% w/w PEI stock was then added to a final concentration 
of 0.1% w/w, and the precipitate was removed by centrifugation.  The soluble fraction 
was diluted to 375 mL (6.25-fold) with a new solution to a final buffer condition of: 40 
mM KCl, 50 mM imidazole, 50 mM arginine, and 50 mM glutamate, 2 mM Tris, pH 7.0.  
This sample was passed through a 0.45 micron filter and loaded onto an equilibrated 5 
mL HiTrap SP column (AP Biotech) and eluted with a salt gradient (0.04 to 2 M KCl).  
The purified protein product eluted in ~500 mM KCl and was confirmed to be ~90% pure 
Rpp30 by SDS PAGE visualized by Coomassie blue staining. 
2.2.3 Protein Purification: Insoluble Fraction 
 The insoluble portion of the lysate was resuspended by sonication in 8 M urea, 25 
mM Tris pH 10.5.  Any fraction that was still insoluble was removed by filtration of the 
supernatant through a 0.45 micron filter.  The sample was loaded onto a 1 mL HiTrap Q 
column (AP Biotech), and the flowthrough containing the protein was adjusted to a pH of 
7.0 with dilute HCl.  This solution was loaded onto an equilibrated 5 mL HiTrap SP 
column (AP Biotech).  The protein was then buffer-exchanged and refolded by 
equilibrating the column with 80 mM KCl, 50 mM imidazole pH 7.0, 50 mM arginine, 50 
mM glutamate.  Finally, an elution gradient (0.08 to 2 M KCl) was run, eluting protein at 
~500 mM KCl, which was confirmed to be ~95% pure Rpp30 by SDS PAGE visualized 
by Coomassie blue staining. 
2.2.4 NMR Data Collection 
 Samples were obtained using the above purification protocols except that 
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transformed cells were grown in M9 minimal media supplemented with 1% Eagle Basal 
Vitamin Mix (Life Technologies, Gaithersburg, MD)57, containing 1 g/liter 15N 
ammonium chloride as the sole nitrogen source.  The protein obtained via the soluble and 
insoluble protocols were separately concentrated to 500 µL and supplemented with D2O 
to 5%.  2D 15N HSQC spectra were recorded on a Bruker DMX-600 spectrometer at 28-
55oC.  Data were processed with NMRPipe58 and NMRView59. 
2.3 Results and Discussion: 
2.3.1 Sample Preparation 
 The Rpp30 gene was readily overexpressed in bacteria.  Substantial protein 
production was observed, but the majority (~60%) of the protein formed inclusion bodies 
and was found in the insoluble fraction after lysis (Fig 2.1).  A high-yield preparation 
was desired, and so a purification protocol was devised for both the soluble and insoluble 
fractions of the lysate. 
 Initial attempts to purify the sample by heating were unsuccessful; the denatured 
contaminant proteins aggregated with native Rpp30, precipitating virtually all of the 
solution’s proteins (Fig 2.2).  In addition, initial attempts to purify the protein by cation 
exchange were also unsuccessful.  Although some pure protein could be eluted from the 
column, most of the protein did not bind to the resin (Fig 2.2), despite the high PI of the 
protein and low salt concentration of the buffer.  Because Rpp30 was already suspected 
to be involved in protein-RNA interactions22,28, we hypothesized that the charged sites of 
the protein were occupied by other macromolecules or fragments, preventing binding to 
the cation exchange resin.  Thus, we needed to remove a substantial portion of 
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contaminants (especially nucleic acid contaminants) before cation exchange purification 
could be achieved. 
 For the soluble fraction of the lysate, this was achieved using selective 
precipitation.  Vapor diffusion assays60 of small amounts of purified protein indicated 
that Rpp30 was particularly soluble at high salt concentrations.  Thus, various conditions 
were screened and it was discovered that a low pH, 1 M salt combination precipitated 
most of the contaminant proteins over ~48 h. while minimizing Rpp30 precipitation.  The 
partially purified sample was then subjected to PEI precipitation to remove nucleic acids.  
Again, the salt concentration was crucial; too much salt prevented PEI binding to nucleic 
acids, and too little salt caused the Rpp30 to precipitate along with the nucleic acids.  
Finally, the mostly-pure sample was diluted further into a low salt solution and loaded 
onto an SP column.  As hoped, binding was no longer a problem, and the protein eluted 
midway through the salt gradient. 
 The insoluble fraction of the lysate could not be subjected to the same treatment 
as the soluble fraction because the urea required to resuspend the fraction prevented 
selective precipitation.  However, since the protein was already denatured, the pH was 
increased to 10.5 to deprotonate as many amino acids as possible and disrupt interactions 
with the negatively charged nucleic-acids.  Then, the solution was passed through an 
anion exchange column.  The still negatively-charged nucleic acid fragments as well as 
the majority of the now negatively-charged contaminant proteins bound to the resin, 
while most of the Rpp30 was retained in the flowthrough.  When the pH of the 
flowthrough was dropped to 7.0, the protein bound to cation exchange resin, although  
again only when virtually no salt was present.  After binding Rpp30 to the resin of an SP 
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column, the protein could be refolded by washing non-denaturing buffer over the column, 
and subsequent elution yielded pure Rpp30. 
 In summary, a purification protocol was established that yielded moderately pure 
protein (>90% pure, as estimated by SDS PAGE) in fairly large quantities (~6 mg Rpp30 
per liter of cell culture).  Also, a collection of results strongly suggests that Rpp30 is 
associating with nucleic acids:  the precipitation of Rpp30 with the addition of PEI in low 
salt but not in high salt, the inclusion of large amounts of nucleic acids in the insoluble 
fraction of the lysate, and the inability of Rpp30 to bind a cation exchange resin despite 
its high PI.  Although association with nucleic acid may well be nonspecific given the 
high PI of the protein, the above results suggest that Rpp30 may readily bind RNA, as has 
been suggested before22,28.  
2.3.2 Preliminary NMR Data 
 Once a substantial quantity of protein had been purified, the next question was 
whether the product would be suitable for the desired NMR experiments.  Before mixing 
the samples obtained from each purification protocol, we needed to determine whether 
the protein from the insoluble preparation refolded properly into the same conformation 
as the native protein.  A rather low concentration sample of 15N Rpp30 purified from each 
of the established protocols was analyzed using an HSQC pulse sequence; a ~150 µM 
sample from the insoluble preparation and ~250 µM sample from the soluble preparation 
were used. 
 An initial temperature screen was conducted for the insoluble preparation sample.  
Varying the temperature from 25-55 oC in 10 degree intervals showed that spectral 
quality improved with increasing temperature (Fig 2.3); temperatures above 55 oC were 
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not used because higher temperatures would be damaging to the cryogenic probe that was 
planned for future experiments.  Although spectral improvement may have been caused 
in part by decreased relaxation times, the improvement of signal was very large, 
suggesting that the hyperthermophile-derived protein was better structured at higher 
temperatures.  Hanging-drop screens of buffer conditions suggested that little 
improvement in signal would be achieved by changing buffer components because the 
protein was maximally soluble at the high-salt, pH 7 condition already observed. 
 Using the temperature-optimized condition, spectra were compared for the protein 
samples derived from the soluble and insoluble preparations.  The spectra were very 
similar, indicating that the refolded protein had the same conformation as the protein that 
had not been denatured (Fig 2.4).  Both spectra were well-dispersed.  A wide range of 1H 
chemical shifts spanning the 6.5-10.5 ppm indicated that the protein had assumed a well-
defined tertiary structure.  An unstructured protein, in contrast, would give a roughly 
homogenous signal spanning from ~7-8 ppm in the hydrogen dimension and resembling 
an unstructured string of amino acids. 
 Unfortunately, the overall clarity of the spectra was less than ideal.  Only 158 
peaks (including those from sidechains) were counted, which is substantially less than 
expected from the 214 backbone residues.  There were large regions of overlap in the 
middle of both spectra, and the overlap was worse in the higher-concentration spectrum 
from the soluble preparation.  Although this might have been caused by Rpp30 
aggregation, it was also the case that the soluble preparation protein was slightly less pure 
than that from the insoluble preparation. Still, observation of the characteristic spectrum 
of a well-folded protein was an important result. 
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Figure 2.1: Induction and solubility of wild-type Rpp30 is illustrated by Coomassie-
stained SDS-PAGE.  Rpp30 can be overexpressed in E. coli (lanes 2 and 3), but is mostly 
present in the insoluble fraction of the lysate (lane 5). 
1) Marker  
2) Uninduced 
Cells 
3) Induced Cells 
4) Soluble Cell 
Lysate 
5) Insoluble Cell 
Lysate 
 Rpp30 (24.5 kDa) 
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Figure 2.2:  Purification of wild-type Rpp30 is described by SDS-PAGE.  Lanes 1-3 
show the inefficacy of heat-purification.  Lane 1 is the soluble lysate, lane 2 is the soluble 
lysate after heating at 55oC for 15 min, and lane 3 is the protein that precipitated during 
the heating process, which includes almost the entire protein content of the sample.  
Lanes 5-9 illustrate the pros and cons of SP cation exchange purification.  Although some 
protein is collected in elution fractions (Lanes 7-9, concentrated), most Rpp30 loaded 
from the soluble lysate (Lane 5) flows through the column (Lane 6). 
Rpp30 
(24.5 kDa)  
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Figure 2.3:  Spectral quality improves drastically with increased temperature.  Improved 
dispersion and linewidth are evident in the amide region of Rpp30’s 1H spectrum (lower 
right inset) when collected at 28 oC (above) and at 55 oC (below).  The improvement is 
even more pronounced in when 15N HSQC spectra from the two temperatures (black 
spectrum collected at 28 oC, red spectrum at 55 oC) are overlaid.  Spectra were collected 
in ~500 mM KCl, 50 mM imidazole pH 7.0, 50 mM arginine, 50 mM glutamate. 
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Figure 2.4:  Sample homogeneity obtained purifying from the soluble (Sol) versus the 
insoluble (Ins) fractions of the cell lysate is visible by SDS-PAGE.  A comparison of 
HSQC spectra shows overall similarity of fold, but the larger proportion of impurities in 
the soluble sample diminishes spectral quality (consider the degree of overlap in the 
center of the spectra) despite the higher concentration of the soluble-purified sample (250 
µM vs. 150 µM). 
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CHAPTER 3 
AFFINITY PURIFICATION OF AN MBP-Rpp30 FUSION PROTEIN 
3.1 Introduction: 
Pfu Rpp30 is a 24.5 kDa protein, which is on the larger end of the molecular-
weight range for proteins amenable to structural characterization by NMR.  As such, the 
demands for well-resolved spectra are particularly high.  Despite the effort invested in 
achieving a moderately high-yield purification of the wild-type protein, the resulting 
HSQC spectra were still far from ideal; fewer than the expected number of peaks were 
observed, largely due to the obfuscating overlap in the central regions of the spectra.  
Because sample homogeneity is so important for NMR spectra, the small amount of 
impurities that could be detected in the sample were suspected to be diminishing the 
spectral quality.  To improve the purity and yield of the protein, we therefore turned to a 
MBP (maltose-binding-protein)-fusion strategy to take advantage of the selectivity of 
affinity chromatography and the solubility-enhancing properties of MBP. 
The pHMT plasmid (Fig 3.1) was employed to create a fusion of Rpp30 that 
could be purified by affinity chromatography.  Three important features of the plasmid 
were advantageous.  Directly upstream of the multiple cloning sites, the plasmid encodes 
the native E. coli maltose-binding-protein.  Upstream from the MBP sequence there is a 
His6 tag, which is preceded by a start codon and promoter region.  Between the His-
tagged MBP and the multiple cloning sites, there is a region coding for the amino acid 
sequence that is recognized by the extremely specific tobacco etch virus (TEV) protease.   
Rpp30 was cloned into pHMT to take advantage of all three features.  Fusion to 
MBP, which is a highly soluble protein, has been suggested to aid the solubility of 
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overexpressed proteins61.  The N-terminal His-tag offers a means of IMAC (immobilized 
metal affinity chromatography) purification, and after purification, both the MBP and the 
His-tag could be removed from Rpp30 using TEV Protease.  MBP can be removed using 
amylose affinity chromatography as well.  Furthermore, if (His)6-tagged TEV Protease 
were used, both the cleaved MBP and the protease could be separated from Rpp30 from 
an additional IMAC step.  Finally, the MBP-fusion form of the protein had potential for 
use in future pulldown experiments using insoluble amylose beads.  We here show that 
this fusion form of the protein yielded a sample of improved purity and high spectral 
quality.  
3.2 Materials and Methods: 
3.2.1 pHMT Cloning:  
The Pfu Rpp30 gene was subcloned from pET33b into the EcoRI and BamHI sites 
of the pHMT vector61 for expression as a fusion to His-6-tagged maltose binding protein 
(MBP); the construct is designed to allow removal of the fusion protein by specific 
cleavage with tobacco etch virus (TEV) protease. Subcloning was accomplished by PCR-
based amplification of Pfu Rpp30/pET33b using the following oligonucleotide primers: 
5'-GGAGAGAATTCATGGCTGGTGGTCGTAATGG-3' and 5'-
GACGGGGATCCTTATCATTTAAGACGTTCCAGAATACC-3', incorporating EcoRI 
and BamHI sites at the 5' and 3' end of the gene, respectively (italicized); the start and 
stop codons are underlined. The identity of the subclone was confirmed by DNA 
sequencing (OSU PMGF Facility).   
3.2.2 TEV Protease Purification: 
The TEV protease used to remove the MBP tag was grown and isolated in-house.  
 30 
The pRK793 plasmid, which encodes a mutant form of TEV protease that is resistant to 
self-cleavage, was obtained from Dr. David Waugh (NCI).  A protocol also provided by 
Dr. Waugh62 was used to guide purification of the protease. 
BL21(DES)-RIL cells containing pRK793 were grown at 37 °C in 1 L flasks of 
LB-media containing 100 µg/ml carbenicillin and 30 µg/ml chloramphenicol.  Cells were 
induced at OD600 ≈ 0.6 with 0.5 mM IPTG and temperature was shifted to 30 
oC for 4 h.  
Cells were centrifuged, then 1/3 of the pellet was resuspended in 10 ml of 50 mM PO
4 
(pH 8.0), 100 mM NaCl, 10% glycerol, and 25 mM imidazole and lysed by sonication.  
PEI (10% w/w stock, pH 8.0) was added to the lysate before centrifugation.  The 
supernatant was passed through a 0.45 micron filter then loaded onto an equilibrated 1 
mL HiTrap Chelating column (AP Biotech) charged with NiSO4.  Contaminants were 
removed using a 0-200 mM imidazole gradient, then pure TEV protease was eluted using 
500 mM imidazole solution.  The product was diluted and DTT and EDTA were added to 
a final solution containing ~1 mg/mL TEV protease (estimated using Bradford reagent), 
25 mM PO
4 
(pH 8.0), 200 mM NaCl, 2 mM EDTA, 5 mM DTT, 10% glycerol, 50 mM 
imidazole.  The final product was stored at -20 oC until needed. 
3.2.3 Rpp30 Expression and Purification: 
  Escherichia coli BL21(DE3) cells were co-transformed with Pfu Rpp30/pHMT 
and pARG-U plasmids63 and grown at 37°C in LB broth supplemented with 34 µg/liter 
chloramphenicol, 50 µg/liter carbenicillin. The cells were induced by addition of 0.5 mM 
IPTG when the cells reached OD600 ≈ 0.6 (mid-log phase), at which point the culture was 
shifted to 30 °C. Cells were harvested after 20 h by centrifugation (15 min, 5,000 × g, 4 
°C), and stored at -20 °C. Thawed cells from 1 liter were suspended in 30 ml of lysis 
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buffer (40 mM imidazole, pH 7.6/500 mM KCl), lysed on ice by sonication, mixed with 
0.1% (wt/vol) PEI, and clarified by centrifugation (15 min, 26,000 × g, 25°C). The 
soluble lysate was passed through a 0.45 µm filter and loaded onto an equilibrated 5 ml 
HisTrap column (AP Biotech), then washed with 50 ml of lysis buffer containing 10% 
glycerol and 25 ml lysis buffer without glycerol. The MBP-fused protein was then eluted 
with (500 mM imidazole pH7.6/500 mM KCl). Fractions containing MBP-fused Rpp30 
were pooled for dialysis against 30 mM imidazole pH 7.6/250 mM KCl. After 16 h of 
dialysis, the protein concentration was estimated from its denatured extinction coefficient 
at 280 nm, 28,590 M-1·cm-1 (http://us.expasy.org/tools/protparam.html), and the solution 
was diluted with dialysis buffer to 80 µM protein. The fusion protein was then cleaved by 
incubation for 1.5 h at 30 °C with a 5% molar equivalent of His-tagged S219V-TEV 
protease64. After cleavage, KCl was added to 500 mM and Rpp30 was purified from the 
His-tagged MBP and TEV protease by passing the solution through a 5-ml HiTrap 
Chelating column (AP Biotech) charged with NiSO4. The flow-through was diluted 
twofold with water and further purified on a 1 ml HiTrap SP column (AP Biotech) eluted 
with a linear salt gradient (0.25-2 M KCl). The final product was confirmed to be >95% 
pure by SDS PAGE visualized by Coomassie blue staining and ESI mass spectrometry 
(provided by OSU CCIC facility; 24827.9 Da expected for GEF-Rpp30 (GEF is residual 
from TEV cleavage site and BamHI cloning site used for the fusion construct); 24,828 Da 
observed) before dialysis against NMR buffer (20 mM sodium acetate, pH 5.0/20 mM 
KCl). Typical yields of pure protein were around 13 mg per liter of rich media (LB). 
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3.2.4 NMR Data Collection 
 Samples were obtained using the above purification protocols except that 
transformed cells were grown in M9 minimal media supplemented with 1% Eagle Basal 
Vitamin Mix (Life Technologies, Gaithersburg, MD)57, containing 1 g/liter 15N 
ammonium chloride as the sole nitrogen source, and D2O was added to the final sample 
to 5%.  2D 15N HSQC and TROSY spectra were collected on a Bruker DMX-800 
spectrometer with a cryogenic probe at 55 oC.  Data were processed with NMRPipe58 and 
NMRView59. 
3.3 Results and Discussion: 
 Creation of the MBP-Rpp30 fusion mutant allowed for a greatly improved 
purification (Fig 3.2).  The protocol was simplified, the yield was roughly doubled, and 
there was no significant contamination observed by Coomassie-stained SDS PAGE or 
ESI mass spectrometry (Fig 3.3).  Mass spectrometry also indicated that the desired 
protein product had been obtained (24827.9 Da expected for GEF-Rpp30; 24,828 Da 
observed).  Solubility was also greatly improved in contrast to samples obtained from the 
wild-type purifications; before, Rpp30’s solubility limit was very low (~150 µM) in low 
salt conditions, and only ~500 µM in 0.5 M KCl, but protein obtained from the affinity 
purification protocol could be concentrated to at least 1.5 mM in only 10 mM sodium 
acetate pH 5.0.  Buffer screenings on this sample suggested that solubility was maximal 
at pH 5.0 in acetate buffer with little dependence on salt concentration.  
The improvement of purity was also manifest in NMR spectra, where a 0.65 mM 
Rpp30 sample in low-salt gave very high-quality spectra from relatively short 
experiments (Fig 3.4).  TROSY experiments were also collected, but the signal-to-noise 
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was slightly lower than the HSQC experiment.  However, the TROSY does not detect 
sidechain nitrogens very well, and so an overlay of the spectra was used to identify 20 
sidechain peaks (Fig 3.5).  Subtracted from the 220 peaks that could be counted in the 
HSQC, this left 200 peaks that could be identified from a 2D spectrum, a large portion of 
the 214 expected resonances from backbone amides. 
Overall, the quality of NMR data strongly supported further characterization of 
the protein.  Not only could we be confident in obtaining useful 3D NMR data with 
relatively few scans, but the high purity of the sample suggested that experiments probing 
Rpp30 interactions would yield interpretable results. 
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Figure 3.1:  A plasmid map for pHMT shows the major features, including a His-tag, an 
MBP-encoding region, a TEV-protease recognition site, and a multiple cloning site. 
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Figure 3 2:  Purification of the MBP-Rpp30 construct was optimized.  In this SDS-
PAGE gel, lanes 4 and 6 compare the insoluble and soluble lysates respectively.  Lanes 7 
and 8 represent protein that flows through the first nickel column of the protocol, and 
lane 9 is the elution product.  Lanes 10-12 are time points from TEV-protease digestion 
of the sample from lane 9, which were subsequently loaded onto a nickel column.  Lanes 
13 and 14 are the flowthrough and early elution fractions containing pure Rpp30, and 
lane 15 is a later elution fraction containing the cleaved MBP tag. 
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Figure 3.3:  No impurities are detectable by SDS-PAGE after the MBP-fusion 
purification (right).  ESI-Mass Spectrometry shows a substantial improvement in sample 
homogeneity between the wild type purification (top) and the MBP-Fusion purification 
(bottom). 
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Figure 3.4:  When overlaid, it is clear that the 15N-HSQC spectrum of Rpp30 obtained 
from immobilized metal affinity chromatography (red) has much more resolution in the 
central region (~7-8 ppm in the HN dimension) of the spectrum than does the protein 
purified without the tag (black) with few other changes overall. 
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Figure 3.5:  An overlay of Rpp30 15N -HSQC (red) and TROSY (black) spectra 
identifies side-chain peaks, which give poor signal in the TROSY experiment.  The 
TROSY spectrum referencing has been corrected for the ½ J-coupling shift in peak 
position.  Both spectra were collected in 20 mM KCl, 20 mM sodium acetate pH 5.0. 
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CHAPTER 4 
INTERACTIONS BETWEEN Pfu Rpp30 AND Pfu Pop5 
4.1 Introduction: 
 The overall aims of the Rpp30 project are to characterize its role in the RNase P 
holoenzyme by investigating subunit interactions.  With the quality sample from Chapter 
3 in hand, investigation of Rpp30 interactions was initiated using isothermal titration 
calorimetry (ITC) and NMR chemical shift perturbations.  Rpp30 is closely associated 
with the RNase P protein Pop5:  an interaction between the two proteins has been 
suggested in all yeast two-hybrid screens reported for their homologues26,27,28, and both 
together can fulfill the protein requirement for a partially reconstituted RNase P (Gopalan, 
unpublished data). Pop5 was the obvious first target for characterizing subunit interactions of 
Rpp30. 
 ITC is a direct technique for observing the thermodynamics of molecular 
interactions.  In an ITC experiment, a ligand or binding partner is titrated into a solution 
containing the molecule of interest.  If the reaction is exothermic, heat is released into the 
solution, chiefly due to the interacting molecules achieving a lower energy state.  Smaller 
heat-releasing effects (such as dilution of the titrant and titrand) can largely be controlled 
for by observing the heat generated when the titrant is titrated into a saturated solution of 
titrand.   
The cell in which the reaction takes place is stirred constantly and, more 
importantly, kept at a constant temperature.  When a binding event causes a change in 
temperature, the instrument must compensate by adjusting the amount of heat energy it is 
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adding to the solution.  The change in power that the instrument must use to maintain the 
constant cell temperature is measured and used to calculate the binding constant (KA), 
stoichiometry (n), and enthalpy change ∆H of a binding event by taking advantage of the 
isothermal environment of the reaction.  With these values, the reaction’s ∆G and ∆S 
values can be readily calculated using the basic thermodynamic formulae:  
∆G = - RTln(K)  and  ∆G = ∆H – T∆S. 
The ultimate relation between the change of heat for the i-th injection (∆qi , 
obtained from integrating the directly measured power with respect to time), the total 
concentration of titrand M, the concentration of titrant L, the volume of the cell, and 
thermodynamic measures comes from the equation:  
 
where  is the root of the equation: 
 
 
in which Yi is the degree of saturation: Yi = ∆[Li]bound/[M]tot.  The full derivation of this 
equation can be found in65.  Data fitting using nonlinear regression allows for the quick 
determination of n, KA, and ∆H from one complete titration. 
NMR chemical shift perturbations are a rather more complex measurement.  The 
chemical shift of a particular peak on an NMR spectrum has a very sensitive dependence 
upon the chemical environment experienced by the atom that gives rise to that peak.  A 
binding event can cause perturbations in the chemical environment of the protein’s atoms 
in a number of ways.  Direct contact or close proximity to the ligand will cause large 
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changes in chemical shifts, while conformational changes in the protein can alter solvent 
exposure and intramolecular contacts of atoms away from the binding site.   
Because it is a chemical event, the binding will have an exchange rate between 
free and bound states.  If binding is tight and the exchange rate between the two states is 
slow, a peak for each present state will appear.  At saturating stoichiometry, only the 
peaks from the bound state will be visible.  If the binding is weak and exchange rate is 
fast, a peak will appear in between the peak positions for the free and bound states 
respectively via signal averaging.  In the intermediate exchange range, the peaks will be 
averaged, but broadened to the point of indetectability.  In any case but intermediate 
exchange, an overlay of a protein’s spectrum in the presence and absence of a ligand or 
binding partner will reveal which peaks are experiencing a new environment due to the 
binding event.  Of course, these data can only be translated into information about the 
molecules of interest if the spectral peaks are assigned to atoms in the protein. 
 HSQC peaks generated from protein backbone amides can be assigned by an 
extended analysis of several 3D spectra.  The HNCO uses a magnetization transfer pulse 
sequence that gives signals only for protons that are covalently attached to a nitrogen that 
is bonded to a carbonyl carbon.  For proteins, this experiment provides a three-
dimensional spectrum in which peaks appear on the C-axis corresponding to the chemical 
shift of the backbone carbonyl carbons and the other two dimensions are defined by the N 
and H chemical shifts of the amide N and H from the preceding residue in the protein’s 
primary sequence.  HNCA peaks appear at points on the C-axis corresponding to the 
chemical shift of α−carbons, and the N and H coordinates are from the same atoms that 
define the HNCO’s H and N coordinates.  For the HNCA, however, the strongest signal 
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correlates an NH group to the α-carbon shift of the same amino acid (the intra-residue 
resonance).  There is a peak that correlates NH coordinates to an α-carbon shift from the 
preceding residue as well (the inter-residue resonance), although this is a weaker signal 
because of the weaker coupling between these atoms. 
 The assignment process involves stringing together all of the peaks of the HNCA 
into a sequence; each intra-residue peak will have the same C-axis chemical shift as the 
inter-residue peak of the next residue in the primary sequence (Fig 4.1).  The task is aided 
by the fact that each amino acid has a characteristic range of chemical shifts for its atoms.  
The carbon atoms of the side chain have the most varied chemical environments and 
therefore the most distinctive chemical shifts.  By placing amino acid identities on a 
particular series of peaks, one can assign a string of consecutive peaks to a string of 
amino acids in the primary sequence of the protein. 
 Due chiefly to overlap issues (many peaks sharing a nearly identical carbon shift), 
the HNCA and HNCO alone are often not sufficient for backbone assignments in 
practice.  But with the aid of the HNCACB (which correlates NH groups to both inter- 
and intra-residue α− and β−carbon shifts) and the CBCA(CO)NH (which correlates the 
inter-residue signals only) (Fig 4.2), most peaks can be assigned for a reasonably small 
protein with a reasonably complete set of signals. 
 Here we report that nearly all of the backbone resonances of Rpp30 have been 
assigned (Fig 4.3).  An interaction between Rpp30 and Pop5 was observed by ITC and 
confirmed by large chemical shift perturbations in the NMR spectra of each protein.  
Mapping the chemical shift perturbations onto structural models of both proteins has 
suggested a binding interface for the two RNase P subunits. 
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 4.2 Materials and Methods: 
4.2.1 Preparation of Complexes 
 Rpp30 was prepared as described in chapter 3 and dialyzed into various buffers 
depending on the experiment.  Pfu Pop5 was prepared by Ross Wilson as described 
earlier29.  The C42S Pop5 mutant was used for ITC experiments.  Unless otherwise noted, 
solutions containing both proteins were prepared by injecting a Pop5 solution into a 
solution containing Rpp30.  NMR samples contained a roughly 1:1 ratio of proteins with 
only one of the proteins 15N labeled per sample.  Concentrations of 125 µM each were 
used for the 15N-Rpp30 spectrum and 260 µM Pop5 with 280 µM Rpp30 were used in the 
15N-Pop5 spectra.  Mixtures of Rpp29 and Rpp30 were 200 µM and were formed by 
titrating one equivalent of unlabeled Rpp29 into 15N Rpp30. 
4.2.2 ITC  
 Unlabeled GEF-Rpp30 and C42S Pop5 were diluted to 20 µM and 200 µM 
respectively.  Proteins were dialyzed together against the same buffer containing only 5 
mM sodium acetate and 0.01% NaN3 pH 5.0, and each sample was degassed for 3 min at 
25 oC.  The Pop5 sample was loaded into the syringe and injected into the Rpp30 solution 
in the cell; the first injection was 3 µL and subsequent injections were 5 µL with a delay 
of 220 s between injections.  The heat of injection was estimated using the non-reacting 
(last 4) injections.  Data were fit with Origin software (MicroCal). 
4.2.3 NMR Data Collection 
Samples used for NMR experiments were either unlabeled (grown in LB-broth) or 
uniformly labeled with either 15N or both 15N and 13C (grown in M9 minimal media 
supplemented with 1% Eagle Basal Vitamin Mix (Life Technologies, Gaithersburg, 
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MD)57, containing 1 g/liter 15N ammonium chloride as the sole nitrogen source and 3 
g/liter 13C glucose as the sole carbon source for 13C labeled samples).  After dialysis into 
the appropriate buffer, samples were concentrated to 500 µL and D2O was added to 5%.   
3D experiments were collected from a 1 mM sample in a buffer containing only 
10mM sodium acetate, 0.01% NaN3, pH 5.0 at 55 
oC on a Bruker DRX-600 spectrometer 
equipped with a cryogenic probe.  2D 15N HSQC experiments of the Rpp30-Pop5 
complex were collected in 15mM sodium acetate, 0. 01% NaN3, pH 5.0 with one 
uniformly 15N labeled protein and one unlabeled protein.  Data was collected on a Bruker 
DMX-800 spectrometer at 55 oC.  Data were processed with NMRPipe58 and 
NMRView59. 
4.3 Results and Discussion: 
4.3.1 Rpp30-Pop5 interaction by ITC 
 ITC data collected on Pop5 titration into Rpp30 are less than ideal.  However, a 
distinct binding curve of roughly 1-to-1 stoichiometry was observed, indicating a 
moderately tight binding event between the two proteins even at 25 oC  (Fig 4.4).  
Although the calculated KD of ~900 nM may not be relevant to the true nature of the 
holoenzyme, the ITC titration gives strong evidence for 1-to-1 binding between Rpp30 
and Pop5 in solution. 
 4.3.2 Rpp30-Pop5 interaction by NMR 
 A distinct interaction between Rpp30 and Pop5 in solution was also detected by 
NMR; major chemical shift perturbations in each protein’s 15N HSQC spectrum were 
observed upon addition of the other protein.  To observe shifts in the Rpp30 spectrum, an 
HSQC spectrum was recorded on 15N labeled protein in the absence and presence of 
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unlabeled Pop5.  Comparing the spectra revealed changes in a large number of peak 
positions, revealing extensive interactions between the proteins (Fig 4.5).  The spectral 
resolution for the sample containing both proteins was comparable to that of isolated 
Rpp30, suggesting that the interaction was specific and tight; non-specific interactions 
would instead produce a heterogeneous sample, degrading the signal substantially.   
Similar results were observed with the same experiment using 15N Pop5.  
Interestingly, when Rpp30 was titrated into a Pop5 solution, the spectrum was all but 
annihilated (Fig 4.6); the reverse titration (Pop5 into Rpp30) gave full spectra (Fig 4.7).  
We suspect that this phenomenon was due to nonspecific aggregation that took place only 
when large quantities of Pop5 are present with limited amounts of Rpp30, perhaps as a 
byproduct of dimerization of the complex. 
4.3.3 Assignment of the Rpp30 Backbone 
 To interpret the chemical shift changes observed in the Rpp30 spectrum upon the 
formation of the Rpp30-Pop5 complex, the Rpp30 backbone residues were assigned.  
HNCO, HNCA, HNCACB, and CBCA(CO)NH spectra were sufficient to assign 191 
residues (Fig 4.3) thanks to a robust sample signal aided by a cryogenic probe.  During 
this time an HCCCONH experiment was also recorded, but the spectral quality was rather 
poor and its data were used sparingly.  Discounting the 14 proline residues and the N-
terminal glycine, the final assigned peak list represents ~95% of the assignable residues.  
These backbone assignments will be critical for any further NMR study of Pfu Rpp30 and 
paves the way to numerous possible experiments for elucidating its role in RNase P, 
including structural characterization. 
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 A prediction of the protein’s secondary structure was calculated based on the 
chemical shifts of each residue using the CSI database comparison66 (Fig 4.8).  The 
predicted secondary structure of Rpp30 in solution is largely consistent with the 
alternating helix-sheet pattern observed in the crystal of the Pho protein.  What little 
deviation can be observed occurs mostly at the N- and C- termini of the protein and 
around residue 100 where NMR data predicts a loop in place of the crystallographically 
observed β-5 strand; none of these three areas is highly conserved. 
4.3.4 Mapping Chemical Shift Perturbations  
  Ideally, Rpp30’s peaks would be completely assigned in both the free and Pop5-
bound states; in that situation, the degree of chemical shift change could be measured for 
each residue and mapped onto a sequence and/or structure with the largest chemical shift 
changes revealing sites of interaction between the two proteins.  Substantial information 
about the ineraction can also be achieved using only the available assignments for free 
Rpp30.  In this case, the spectrum of the complex could be partially reassigned using a 
quick and inexpensive HSQC experiment.  Non-overlapping peaks that did not shift at all 
were easily reassigned, and in the peripheral regions of the spectrum a number of small 
and medium shift perturbations could be unambiguously reassigned.  Although the shifts 
of many residues in the protein still could not be determined using this technique, the 
preliminary results of the 2D experiment are still informative. 
 The magnitude of the measured chemical shift perturbation was mapped onto the 
primary sequence of Rpp30.  Using a homology model of the protein based on the highly 
homologous Pho Rpp30 crystal structure (model generated using SWISS-MODEL:  
http://swissmodel.expasy.org//SWISS-MODEL.html), the magnitudes could be mapped 
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onto a three-dimensional model as shown in Fig 4.9.  The largest shifts were generally 
localized to one face of the protein, with moderate shifts observed in the central pore.  
This suggests that Rpp30 binds Pop5 on the region surrounding helix-10 with some 
degree of conformational change. 
 Data from an HNCO of the complex with unlabeled Rpp30 and uniformly 15N and 
13C labeled Pop5 allowed Ross Wilson to reassign ~60% of the Pop5 peaks, and mapping 
the chemical shift changes revealed a likely reciprocal interface on the Pop5 crystal 
structure (Fig 4.10).  Our results are consistent with the hypothesis that Pop5 (which 
adopts the RNA Recognition Motif fold) binds to RNA in a similar fashion as the 
bacterial RNase P protein: Rpp30 binds to a face that would not be involved with the 
suspected RNA-binding.  The binding interface identified for each protein in solution is 
consistent with a recently published crystal structure of the Rpp30-Pop5 complex from 
Pho (Fig 4.11).  The crystal structure showed only a 0.6 Å RMS deviation between 
Rpp30 free and bound, indicating almost no structural change upon binding.  However, 
even small changes in conformation could translate into significant alterations in 
chemical environment for the protein’s constituent atoms. 
 In contrast to the results observed upon with addition of Pop5, titrating one 
equivalent of unlabeled Rpp29 into 15N-Rpp30 produced almost no spectral perturbations 
(Fig 4.12).  What few (< 10) peaks that showed minor movement were unassigned.  Such 
minor changes in the spectrum are inconsistent with an intimate interaction between these 
proteins under the given conditions. 
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4.3.5 Conclusions and Future Directions 
  Identification of a Pop5-Rpp30 interface is an important step toward 
understanding how each protein is involved in the holoenzyme, and we now have reason 
to suspect that there is no specific Rpp29-Rpp30 interaction, which will simplify future 
experiments involving both proteins.  The door is open to investigate other Rpp30 
interactions on the way to understanding its functional role. 
 Particularly, it will be interesting to see how the protein is interacting with the 
catalytic RNA subunit and the substrate tRNA to elucidate the role of protein-RNA 
interactions in the holoenzyme.  Electrophoretic mobility shift assays involving Rpp30 or 
the Rpp30-Pop5 complex combined with an RNA subunit or truncated version thereof 
will be the first step in characterizing the relationship between protein and RNA subunits.  
On top of chemical shift perturbations, there are a variety of NMR techniques available 
that may be used advance our understanding of the interactions in more detail, including 
experiments that measure H/D exchange, residual dipolar couplings, molecular cross-
saturation, or the full solution structure of various Rpp30 complexes.  A full structure of 
the holoenzyme would likewise be informative, and crystallographic work toward that 
end is already underway. 
 In addition, a more detailed description of the Rpp30-Pop5 interaction will inform 
experiments involving the holoenzyme.  For instance, more ITC data would provide the 
KD of complex formation, which is an important parameter for future reconstitution and 
crystallization efforts.  Also, the binding interface could be defined with greater precision 
by recording 3D spectra of labeled Rpp30 in complex with Pop5, which would allow 
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further site-directed mutagenesis experiments to be conducted, probing the significance 
of the interaction. 
 In all, these are small but necessary steps in coming to a better understanding of 
RNase P, which is itself a small but important component of every cell’s existence. 
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Figure 4.1:  Strip plots from the Rpp30 HNCA spectrum demonstrate how to relate 
NMR peaks of a particular residue to its relative location in the primary sequence.  Each 
strip displays a small ppm range for the 15N and HN dimensions and contains two 
different peaks in the 13C (vertical) dimension, which represent the resonances from the 
inter-residual and intra-residual α-carbons.  Identical carbon shifts can be found for 
adjacent residues, linking neighboring amino acids.  The strips are labeled with the 
identity of the corresponding residue. 
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Figure 4.2:  Using spin-echo pulse sequences to selectively transfer nuclear excitation 
between atoms is crucial for NMR characterization of proteins.  Above are the pathways 
of magnetization transfer along the backbone of the protein for the CBCA(CO)NH 
(yellow) and HNCACB (blue) experiments.  The CBCA(CO)NH relates an amide proton 
to the sidechain carbons of the preceding residue, whereas the HNCACB relates the 
amide proton to both inter-residual and intra-residual sidechain carbons. 
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Figure 4.3:  Peaks of the Rpp30 HSQC are labeled according to backbone assignments.  
The number corresponding to the residue’s position in the primary sequence appears to 
the upper-right of each assigned peak.  The central region of the spectrum has been 
expanded in the upper left for clarity. 
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Figure 4.4:  ITC curve of Pop5 (21 µM protein) titrated into Rpp30 (210 µM protein) 
shows a sigmoidal curve characteristic of a one-to-one binding event.  The data was 
collected at 25 oC in 10 mM sodium acetate, pH 5.0. 
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Figure 4.5:  An overlay of HSQC spectra for free Rpp30 (black) and Rpp30 bound to 
Pop5 present in 1:1 stoichiometry (blue) shows that a large number of Rpp30’s amide 
protons experience a different chemical environment in the absence and presence of 
Pop5.  Such extensive effects are likely to be caused by specific protein-protein 
interactions in the given condition of 10 mM sodium acetate, pH 5.0. 
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Figure 4.6:  Titration of Rpp30 into 15N-labeled Pop5 abolishes the spectral resolution as 
is observable by the disappearance of the majority of peaks as the titration proceeds.   
The spectrum of free Pop5 (black) is overlaid with the following Pop5-to-Rpp30 
stoichiometries:  4:1 (red), 2:1 (green), 1:1 (blue).  This result is likely caused by 
aggregation of the complex or nonspecific binding that occurs when few Rpp30 
molecules are available in an excess of Pop5. 
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Figure 4.7:  An overlay of HSQC spectra for free Pop5 (black) and Pop5 bound to 
Rpp30 in 1:1 stoichiometry (red) when Pop5 is titrated into an Rpp30 solution again 
shows major spectral changes indicative of a specific interaction between the two 
proteins.  It is also notable that the spectral quality of Pop5 is reduced when bound to 
Rpp30, which could be caused by increased relaxation (due to increased hydrodynamic 
radius) or heterogeneity in the complex interface. 
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Figure 4.8:  CSI secondary structure prediction for Pfu Rpp30 is compared to that of the 
Pho Rpp30 crystal structure.  Rows of red and blue dots represent helical and strand-like 
chemical shifts respectively for (from top to bottom) amide protons, alpha carbons, 
carbons, and nitrogens of each backbone residue.  The cartoon in gray under each 
segment is a predicted structural element based on a computation using each atom66.  The 
cartoon in color represents the secondary structure of Pho Rpp30 described in 35, whose 
211 residue sequence can be aligned with Pfu Rpp30’s almost exactly.   
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Figure 4.9:  Magnitudes of peak shifts were mapped onto this homology model of Pfu 
Rpp30 based on the Pho crystal structure.  Although much of the protein (gray) was not 
reassigned, the color gradient from blue (no change) to red (big change) shows that most 
of the identifiable peak movements were localized to one side of structure (the right in 
this figure). 
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Figure 4.10:  Pop5 residues labeled with a color ramp from gray to green to indicate 
minor to major chemical shift perturbations respectively show that major NMR peak 
movements are generally localized to one face (left side of figure) of the protein’s 
structural model.  Black residues correspond to amino acids whose chemical shift change 
could not be determined unambiguously from the HNCO. 
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Figure 4.11:  The Rpp30-Pop5 interface identified by NMR chemical shift changes 
corresponds well to a recently published crystal structure of the complex from Pho34, 
shown here in two orientations.  The crystal comprises four subunits with two Rpp30 
monomers (gold and blue) flanking two interacting Pop5 monomers (green and red).  The 
secondary structural elements most involved in the interface are labeled for Rpp30 in the 
top figure and for Pop5 in the bottom figure.   
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Figure 4.12:  Overlaying HSQC spectra for Rpp30 free (black) and in the presence of 
one equivalent of Rpp29 (red) reveals almost no spectral changes.  There is therefore not 
a major interaction between the two proteins in the condition tested. 
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